Post-operative Mobilization for Carpal Tunnel Syndrome
This study will investigate the effect of one week of immobilization following carpal tunnel release surgery versus no immobilization...
Brief Summary
Official Title: “Post-operative Mobilization for Carpal Tunnel”
This study will investigate the effect of one week of immobilization following carpal tunnel release surgery versus no immobilization.
- Study Type: Interventional
- Study Design: Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment
- Study Primary Completion Date: February 2011
Intervention(s) in this Clinical Trial
- Procedure: Carpal tunnel release surgery
- Patient will have carpal tunnel release surgery and will be put in a splint after surgery.
- Procedure: Carpal tunnel release surgery
- Patient will have carpal tunnel release surgery and will have a bandage placed over the incision site after surgery.
Arms, Groups and Cohorts in this Clinical Trial
- Active Comparator: 1
- Active Comparator: 2
Outcome Measures for this Clinical Trial
Primary Measures
- Function assessment questionnaire score, pain score questionnaire, and measurements will be used to determine outcome.
- Time Frame: 6 months
Safety Issue?: No
- Time Frame: 6 months
Criteria for Participation in this Clinical Trial
Inclusion Criteria:
- Patients undergoing open carpal tunnel release will be included in this study.
- Patients must have clinical evidence of carpal tunnel syndrome.
- Patients must have positive EMG results.
- English speaking patients only.
Patient selection factors include:
- Ability and willingness to follow instructions.
- Patients who are able and willing to return for follow-up evaluations.
- Patients of all races and genders.
- Patients who are able to follow care instructions.
Exclusion Criteria:
- Patients less than 18 years old.
- Patients who are pregnant.
- Patients unwilling or unable to comply with a rehabilitation program for carpal tunnel release who indicate difficulty or inability to return for follow-up visits prescribed by the study protocol.
- Patients who qualify for inclusion in the study, but refuse consent to participate in the study.
Gender Eligibility for this Clinical Trial: Both
Minimum Age for this Clinical Trial: 18 Years
Maximum Age for this Clinical Trial: N/A
Are Healthy Volunteers Accepted for this Clinical Trial?: No
Clinical Trial Investigator Information
Lead Investigator: Vanderbilt University Other
Overall Clinical Trial Officials and Contacts
Julie Daniels, BBA Study Director VUMC
Additional Information
Information obtained from ClinicalTrials.gov on February 12, 2012
Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00435149
Study ID Number: 060974
ClinicalTrials.gov Identifier: NCT00435149
Health Authority: United States: Institutional Review Board
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is:
http://clinicaltrialsfeeds.org/clinical-trials/show/NCT00435149
